Inventor · disambiguated record
Qi Sun
Also filed as: SUN QI
8 granted patents·10 pending applications·14 citations·filing 2008–2024
79Inventor score
Files withBOEHRINGER INGELHEIM INT4BOEHRINGER INGELHEIM INTL GMBH CORP4HUANG YU LIANG2UNIV VANDERBILT2BIODURO BEIJING CO LTD1
Top patents by PatentIndex Score
18 records- 0187US10786551B2Use of interleukin-22 in the treatment of fatty liver diseaseGENERON SHANGHAI CORP LTD·Filed 2017·Granted Sep 29, 2020·3 cites·12 claims
- 0286US10501421B1Substituted benzimidazoles as modulators of Ras signalingUNIV VANDERBILT·Filed 2017·Granted Dec 10, 2019·6 cites·16 claims
- 0376US11625514B2Numerical simulation method of pulsed laser paint removal and use thereofUNIV JIANGSU·Filed 2021·Granted Apr 11, 2023·1 cites·10 claims
- 0474US8956605B2Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22HUANG YU LIANG·Filed 2010·Granted Feb 17, 2015·4 cites·9 claims
- 0562US12060367B2Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2023·Granted Aug 13, 2024·0 cites·49 claims
- 0662US2025002504A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0758US11945812B2Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2021·Granted Apr 2, 2024·0 cites·39 claims
- 0857US2011262385A1Use of interleukin-22 in the treatment of fatty liver diseaseHUANG YU LIANG·Filed 2008·Application pending·0 cites
- 0956US2023227470A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1055US2025099573A1Sars-cov-2 s protein polypeptide antigen and application thereofCHINESE PLA GENERAL HOSPITAL·Filed 2022·Application pending·0 cites
- 1155US2025313553A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 1254US11879015B2Antibodies or antigen-binding fragments that bind to OX40BIODURO BEIJING CO LTD·Filed 2022·Granted Jan 23, 2024·0 cites·10 claims
- 1354US2025296940A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 1454US2025129095A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 1554US2014377222A1Use of interleukin-22 in the treatment of fatty liver diseaseGENERON SHANGHAI CORP·Filed 2014·Application pending·0 cites
- 1653US2025129096A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 1753US2010160657A1Synthetic mimics of mammalian cell surface receptors: method and compositionsPENN STATE RES FOUND·Filed 2009·Application pending·0 cites
- 1838US11318137B2Quinazoline compounds as modulators of Ras signalingUNIV VANDERBILT·Filed 2017·Granted May 3, 2022·0 cites·41 claims
Join the waitlist — get patent alerts
Get an alert when Qi Sun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →